Literature DB >> 31515045

Risk stratification in primary sclerosing cholangitis: It's time to move on from replicating imperfection and break the glass ceiling.

Palak J Trivedi1.   

Abstract

Entities:  

Keywords:  Amsterdam Oxford PSC score; Biomarker; Clinical trial; Endpoint; PREsTo; Prognostic model; UK PSC risk score

Mesh：

Year:  2019        PMID： 31515045     DOI： 10.1016/j.jhep.2019.08.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

1.  A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.

Authors:  Emmanuel A Selvaraj; Ahmed Ba-Ssalamah; Sarah Poetter-Lang; Gerard R Ridgway; J Michael Brady; Jane Collier; Emma L Culver; Adam Bailey; Michael Pavlides
Journal:  Hepatol Commun       Date:  2021-11-21

2.  Gadoxetic acid-enhanced MRI in primary sclerosing cholangitis: added value in assessing liver function and monitoring disease progression.

Authors:  Aboelyazid Elkilany; Dominik Geisel; Tobias Müller; Andreas Fischer; Timm Denecke
Journal:  Abdom Radiol (NY)       Date:  2020-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.